Minding Your Business

Proskauer’s perspective on developments and trends in commercial litigation.

Tag Archives: Intellectual Property

Generic Competition for Withdrawn Drug Products

When a pharmaceutical company withdraws a product from the market, the basis for the withdrawal can affect whether a competitor can commercialize a generic version of that product. A generic cannot be approved if, in the FDA’s view, the product was withdrawn for “safety and effectiveness” reasons. But how does the FDA reach that conclusion? … Continue Reading

Caltech Ten-Figure Patent Verdict Showcases Impact of University Intellectual Property

A California jury recently ordered Apple, Inc. (“Apple”) and Broadcom, Ltd. (“Broadcom”) to pay the California Institute of Technology (“Caltech”) over $1.1 billion in damages for infringing several patents owned by Caltech.  The patents relate to a type of error correction code used in wireless technology (known as “irregular repeat and accumulate” codes) to improve … Continue Reading
LexBlog